Leadership & Governance

Meet the members of CanPath’s Leadership Team, Operations Committee, National Strategic Advisory Council and more.

Scientific Directors

The Leadership Team provides guidance and leadership to CanPath’s pan-Canadian strategic directions, scientific priorities, continuing development and oversight of operations, including the development and approval of strategic plans, and approval of operational workplans that guide CanPath’s establishment, implementation, usage and sustainability.

Operations Committee

The CanPath Operations Committee is composed of the Scientific Directors and Operations Leads from each regional cohort, the CanPath Executive Director, the Ethical, Legal and Social Issues Standing Committee Chair, the Harmonization Standing Committee Chair, and the Biosamples Standing Committee Chair.

It provides operational input on strategic plans and scientific priorities while determining work plans for CanPath Committees, Working Groups, and potentially ad-hoc Task Forces as needed, in consultation with the Leadership Team.

Operations Committee Members

  • Philip Awadalla
    National Scientific Director, CanPath; Executive Scientific Director of the Ontario Health Study
  • Parveen Bhatti
    Co-Scientific Director, BC Generations Project
  • Philippe Broët
    Co-Scientific Director of CARTaGENE
  • Trevor Dummer
    Co-scientific Director, BC Generations Project; National Scientific Co-Director
  • Simon Gravel
    Co-Scientific Director of CARTaGENE
  • Shandra Harman
    Strategic Director, Alberta’s Tomorrow Project
  • Jason Hicks
    Executive Director, Atlantic PATH
  • Guillaume Lettre
    Co-Scientific Director of CARTaGENE
  • John McLaughlin
    Executive Director, CanPath
  • Donna Turner
    Scientific Director, The Manitoba Tomorrow Project
  • Jennifer Vena
    Scientific Director, Alberta’s Tomorrow Project
  • Ma’n Zawati
    Ethical, Legal and Social Issues Committee Chair
  • Isabel Fortier
    Harmonization Standing Committee Chair
  • Peter Watson
    Biosamples Standing Committee Chair
  • Kelly McDonald
    Program Manager, Ontario Health Study
  • Ellen Sweeney
    Director, Strategic Research Initiatives, Atlantic PATH
  • Nolwenn Noisel
    Research Associate, CARTaGENE
  • Kristi Rosko
    Research Operations Lead, Alberta’s Tomorrow Project
  • Nikita Lysenko
    Epidemiology Research Coordinator, The Manitoba Tomorrow Project
  • Treena McDonald
    National Biosample Coordinator, BC Generations Project
  • Tedd Konya
    Research Operations Manager, CanPath

Advisory Boards & Committees

International Scientific Advisory Board

The purpose of the ISAB is to advise CanPath on mechanisms to maximize the scientific value and merit of the platform, including providing advice to ensure CanPath activities meet high international standards of scientific excellence.

  • Stephen Chanock, Chair
    National Cancer Institute
  • Naomi Allen
    University of Oxford
  • Nancy Cox
    Vanderbilt University
  • Edward Dove
    University of Edinburgh
  • Marc Gunter
    Imperial College London
  • Teri Manolio
    National Human Genome Research Institute
  • Jill Reedy
    National Cancer Institute
  • John Spinelli
    University of British Columbia
  • Roel Vermeulen
    Utrecht University

National Strategic Advisory Council

A forum for sponsors, funders and key national organizations to provide advice and recommendations to the Executive Leads on the strategic direction of CanPath.

  • Vivek Goel, Co-Chair
    University of Toronto
  • Christine Williams, Co-Chair
    Ontario Institute for Cancer Research
  • François Bénard
    BC Cancer
  • Adalsteinn Brown
    Dalla Lana School of Public Health
  • Timothy Buckland
    Alberta Health Services
  • Brenda Hubley
    Alberta Health Services
  • Garth Matheson
    Cancer Care Ontario
  • Roger S.McLeod
    Dalhousie University
  • Jacques Michaud
    CHU Saint-Justine
  • Theresa Radwell
    Alberta Cancer Foundation
  • Rami Rahal
    Canadian Partnership Against Cancer
  • Stephen Robbins
    Canadian Institutes for Health Research
  • Paula Robson
    Alberta Health Services
  • Anne Simard
    Heart and Stroke Foundation
  • Daniel Tessier
    Genome Quebec
  • Neil Watkins
    Cancer Care Manitoba
  • James Yip
    Alberta Cancer Foundation

Access Committee

The Access Committee reviews and makes approval decisions on research applications submitted for CanPath data and/or biological samples. The committee is composed of 6 independent members from across Canada who have expertise in such relevant fields as biostatistics, epidemiology, and genomics.

Biosamples Standing Committee

The Biosamples Standing Committee provides sample counsel and input that have impact at the pan-Canadian level, as well as enhancing the level of sample coordination and best practice sharing at the regional level of the project.

It ensures that biosamples are collected, processed and stored in each CanPath region according to a core set of operating procedures that reflect as much consistency across the Regions as possible.

Ethical, Legal and Social Issues Committee

The Ethical, Legal and Social Issues Committee (ELSI) Committee is responsible for advising on governance issues and emergent ethical, legal and social issues.

It produces Statements and Discussion Papers to be disseminated within CanPath nationally and regionally. Statements and Discussion Papers covered by the mandate of the ELSI Standing Committee include, but are not limited to: governance of the CanPath project, linkage, data management and sharing in the era of systems thinking research, ethics & scientific communication, the return of results & incidental findings, and, re-consent.

Harmonization Standing Committee

The Harmonization Standing Committee coordinates cohort data activities, provides recommendations on issues that impact data harmonization and data quality at the pan-Canadian level, and establishs the expected level of coordination and best practice sharing on matters related to harmonization at the regional level.